Hypersomnia Drug Market, Global Outlook and Forecast 2023-2028

Report ID: 1569184 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Hypersomnia Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hypersomnia Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hypersomnia Drug Overall Market Size
    2.1 Global Hypersomnia Drug Market Size: 2021 VS 2028
    2.2 Global Hypersomnia Drug Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hypersomnia Drug Players in Global Market
    3.2 Top Global Hypersomnia Drug Companies Ranked by Revenue
    3.3 Global Hypersomnia Drug Revenue by Companies
    3.4 Top 3 and Top 5 Hypersomnia Drug Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Hypersomnia Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hypersomnia Drug Players in Global Market
        3.6.1 List of Global Tier 1 Hypersomnia Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hypersomnia Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Hypersomnia Drug Market Size Markets, 2021 & 2028
        4.1.2 Provigil
        4.1.3 Xyrem
        4.1.4 Others
    4.2 By Type - Global Hypersomnia Drug Revenue & Forecasts
        4.2.1 By Type - Global Hypersomnia Drug Revenue, 2017-2022
        4.2.2 By Type - Global Hypersomnia Drug Revenue, 2023-2028
        4.2.3 By Type - Global Hypersomnia Drug Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hypersomnia Drug Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Hypersomnia Drug Revenue & Forecasts
        5.2.1 By Application - Global Hypersomnia Drug Revenue, 2017-2022
        5.2.2 By Application - Global Hypersomnia Drug Revenue, 2023-2028
        5.2.3 By Application - Global Hypersomnia Drug Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Hypersomnia Drug Market Size, 2021 & 2028
    6.2 By Region - Global Hypersomnia Drug Revenue & Forecasts
        6.2.1 By Region - Global Hypersomnia Drug Revenue, 2017-2022
        6.2.2 By Region - Global Hypersomnia Drug Revenue, 2023-2028
        6.2.3 By Region - Global Hypersomnia Drug Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Hypersomnia Drug Revenue, 2017-2028
        6.3.2 US Hypersomnia Drug Market Size, 2017-2028
        6.3.3 Canada Hypersomnia Drug Market Size, 2017-2028
        6.3.4 Mexico Hypersomnia Drug Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Hypersomnia Drug Revenue, 2017-2028
        6.4.2 Germany Hypersomnia Drug Market Size, 2017-2028
        6.4.3 France Hypersomnia Drug Market Size, 2017-2028
        6.4.4 U.K. Hypersomnia Drug Market Size, 2017-2028
        6.4.5 Italy Hypersomnia Drug Market Size, 2017-2028
        6.4.6 Russia Hypersomnia Drug Market Size, 2017-2028
        6.4.7 Nordic Countries Hypersomnia Drug Market Size, 2017-2028
        6.4.8 Benelux Hypersomnia Drug Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Hypersomnia Drug Revenue, 2017-2028
        6.5.2 China Hypersomnia Drug Market Size, 2017-2028
        6.5.3 Japan Hypersomnia Drug Market Size, 2017-2028
        6.5.4 South Korea Hypersomnia Drug Market Size, 2017-2028
        6.5.5 Southeast Asia Hypersomnia Drug Market Size, 2017-2028
        6.5.6 India Hypersomnia Drug Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Hypersomnia Drug Revenue, 2017-2028
        6.6.2 Brazil Hypersomnia Drug Market Size, 2017-2028
        6.6.3 Argentina Hypersomnia Drug Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hypersomnia Drug Revenue, 2017-2028
        6.7.2 Turkey Hypersomnia Drug Market Size, 2017-2028
        6.7.3 Israel Hypersomnia Drug Market Size, 2017-2028
        6.7.4 Saudi Arabia Hypersomnia Drug Market Size, 2017-2028
        6.7.5 UAE Hypersomnia Drug Market Size, 2017-2028
7 Players Profiles
    7.1 Teva
        7.1.1 Teva Corporate Summary
        7.1.2 Teva Business Overview
        7.1.3 Teva Hypersomnia Drug Major Product Offerings
        7.1.4 Teva Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.1.5 Teva Key News
    7.2 Jazz Pharmaceuticals
        7.2.1 Jazz Pharmaceuticals Corporate Summary
        7.2.2 Jazz Pharmaceuticals Business Overview
        7.2.3 Jazz Pharmaceuticals Hypersomnia Drug Major Product Offerings
        7.2.4 Jazz Pharmaceuticals Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.2.5 Jazz Pharmaceuticals Key News
    7.3 BIOPROJET
        7.3.1 BIOPROJET Corporate Summary
        7.3.2 BIOPROJET Business Overview
        7.3.3 BIOPROJET Hypersomnia Drug Major Product Offerings
        7.3.4 BIOPROJET Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.3.5 BIOPROJET Key News
    7.4 AVADEL PHARMACEUTICALS
        7.4.1 AVADEL PHARMACEUTICALS Corporate Summary
        7.4.2 AVADEL PHARMACEUTICALS Business Overview
        7.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Major Product Offerings
        7.4.4 AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.4.5 AVADEL PHARMACEUTICALS Key News
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporate Summary
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Hypersomnia Drug Major Product Offerings
        7.5.4 GlaxoSmithKline Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.5.5 GlaxoSmithKline Key News
    7.6 Pfizer
        7.6.1 Pfizer Corporate Summary
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Hypersomnia Drug Major Product Offerings
        7.6.4 Pfizer Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.6.5 Pfizer Key News
    7.7 Theranexus
        7.7.1 Theranexus Corporate Summary
        7.7.2 Theranexus Business Overview
        7.7.3 Theranexus Hypersomnia Drug Major Product Offerings
        7.7.4 Theranexus Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.7.5 Theranexus Key News
    7.8 Fisher & Paykel Healthcare
        7.8.1 Fisher & Paykel Healthcare Corporate Summary
        7.8.2 Fisher & Paykel Healthcare Business Overview
        7.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Major Product Offerings
        7.8.4 Fisher & Paykel Healthcare Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.8.5 Fisher & Paykel Healthcare Key News
    7.9 Drive Medical
        7.9.1 Drive Medical Corporate Summary
        7.9.2 Drive Medical Business Overview
        7.9.3 Drive Medical Hypersomnia Drug Major Product Offerings
        7.9.4 Drive Medical Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.9.5 Drive Medical Key News
    7.10 Merck
        7.10.1 Merck Corporate Summary
        7.10.2 Merck Business Overview
        7.10.3 Merck Hypersomnia Drug Major Product Offerings
        7.10.4 Merck Hypersomnia Drug Revenue in Global Market (2017-2022)
        7.10.5 Merck Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Hypersomnia Drug Market Opportunities & Trends in Global Market
    Table 2. Hypersomnia Drug Market Drivers in Global Market
    Table 3. Hypersomnia Drug Market Restraints in Global Market
    Table 4. Key Players of Hypersomnia Drug in Global Market
    Table 5. Top Hypersomnia Drug Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Hypersomnia Drug Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Hypersomnia Drug Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Hypersomnia Drug Product Type
    Table 9. List of Global Tier 1 Hypersomnia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Hypersomnia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Hypersomnia Drug Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Hypersomnia Drug Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Hypersomnia Drug Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Hypersomnia Drug Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Hypersomnia Drug Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Hypersomnia Drug Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
    Table 30. Teva Corporate Summary
    Table 31. Teva Hypersomnia Drug Product Offerings
    Table 32. Teva Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 33. Jazz Pharmaceuticals Corporate Summary
    Table 34. Jazz Pharmaceuticals Hypersomnia Drug Product Offerings
    Table 35. Jazz Pharmaceuticals Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 36. BIOPROJET Corporate Summary
    Table 37. BIOPROJET Hypersomnia Drug Product Offerings
    Table 38. BIOPROJET Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 39. AVADEL PHARMACEUTICALS Corporate Summary
    Table 40. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Offerings
    Table 41. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithKline Corporate Summary
    Table 43. GlaxoSmithKline Hypersomnia Drug Product Offerings
    Table 44. GlaxoSmithKline Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 45. Pfizer Corporate Summary
    Table 46. Pfizer Hypersomnia Drug Product Offerings
    Table 47. Pfizer Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 48. Theranexus Corporate Summary
    Table 49. Theranexus Hypersomnia Drug Product Offerings
    Table 50. Theranexus Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 51. Fisher & Paykel Healthcare Corporate Summary
    Table 52. Fisher & Paykel Healthcare Hypersomnia Drug Product Offerings
    Table 53. Fisher & Paykel Healthcare Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 54. Drive Medical Corporate Summary
    Table 55. Drive Medical Hypersomnia Drug Product Offerings
    Table 56. Drive Medical Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
    Table 57. Merck Corporate Summary
    Table 58. Merck Hypersomnia Drug Product Offerings
    Table 59. Merck Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Hypersomnia Drug Segment by Type in 2021
    Figure 2. Hypersomnia Drug Segment by Application in 2021
    Figure 3. Global Hypersomnia Drug Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Hypersomnia Drug Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Hypersomnia Drug Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Hypersomnia Drug Revenue in 2021
    Figure 8. By Type - Global Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 12. US Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 16. Germany Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 17. France Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 24. China Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 28. India Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 30. Brazil Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Hypersomnia Drug Revenue Market Share, 2017-2028
    Figure 33. Turkey Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
    Figure 37. Teva Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Jazz Pharmaceuticals Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. BIOPROJET Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithKline Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Pfizer Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Theranexus Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Fisher & Paykel Healthcare Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Drive Medical Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Merck Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Hypersomnia Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hypersomnia Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hypersomnia Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Brain Fitness Market

Brain fitness is an umbrella term for techniques and strategies such as mental and cognitive trai ... Read More